Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on: June 12,2024 3

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on:June 12,2024 3

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024 4

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024 4

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024 5

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024 5

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on: June 06,2024 6

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on:June 06,2024 6

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on: June 06,2024 3

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on:June 06,2024 3

Alcohol-related liver disease: Mechanism could form basis for development of new therapies

by Medical University of ViennaCredit: AI-generated imageAlcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of

Updated on: June 06,2024 5

Alcohol-related liver disease: Mechanism could form basis for development of new therapies

by Medical University of ViennaCredit: AI-generated imageAlcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of

Updated on:June 06,2024 5

Study shows seladelpar beneficial for patients with primary biliary cholangitis

by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p

Updated on: June 04,2024 6

Study shows seladelpar beneficial for patients with primary biliary cholangitis

by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p

Updated on:June 04,2024 6

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on: June 03,2024 8

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on:June 03,2024 8

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on: June 01,2024 6

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on:June 01,2024 6

Inosine is a promising metabolite for enhancing mitochondrial function and cellular potency

Updated on: May 29,2024 0

Inosine is a promising metabolite for enhancing mitochondrial function and cellular potency

Updated on:May 29,2024 0

Using social determinants of health to guide liver disease screening

by Ariana Baldassano,Rush University Medical CenterCredit:JHEP Reports(2023). DOI: 10.1016/j.jhepr.2023.100696Black people face a higher risk of developing severe liver fibrosis, but

Updated on: May 29,2024 8

Using social determinants of health to guide liver disease screening

by Ariana Baldassano,Rush University Medical CenterCredit:JHEP Reports(2023). DOI: 10.1016/j.jhepr.2023.100696Black people face a higher risk of developing severe liver fibrosis, but

Updated on:May 29,2024 8

New standards to quantify hepatitis B virus reservoirs in liver cells

by Nicola Wittekindt, Deutsches Zentrum für InfektionsforschungThe effect of different DNA extraction methods on cccDNA quantification by qPCR and SB in HBV-infected USG mouse liver tissue. (A) Schema

Updated on: May 29,2024 7

New standards to quantify hepatitis B virus reservoirs in liver cells

by Nicola Wittekindt, Deutsches Zentrum für InfektionsforschungThe effect of different DNA extraction methods on cccDNA quantification by qPCR and SB in HBV-infected USG mouse liver tissue. (A) Schema

Updated on:May 29,2024 7